Literature DB >> 18394988

Eph-ephrin bidirectional signaling in physiology and disease.

Elena B Pasquale1.   

Abstract

Receptor tyrosine kinases of the Eph family bind to cell surface-associated ephrin ligands on neighboring cells. The ensuing bidirectional signals have emerged as a major form of contact-dependent communication between cells. New findings reveal that Eph receptors and ephrins coordinate not only developmental processes but also the normal physiology and homeostasis of many adult organs. Imbalance of Eph/ephrin function may therefore contribute to a variety of diseases. The challenge now is to better understand the complex and seemingly paradoxical signaling mechanisms of Eph receptors and ephrins, which will enable effective strategies to target these proteins in the treatment of diseases such as diabetes and cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394988     DOI: 10.1016/j.cell.2008.03.011

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  564 in total

1.  A role for epha2 in cell migration and refractive organization of the ocular lens.

Authors:  Yanrong Shi; Alicia De Maria; Thomas Bennett; Alan Shiels; Steven Bassnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

2.  Cancer cells exploit the Eph-ephrin system to promote invasion and metastasis: tales of unwitting partners.

Authors:  Bingcheng Wang
Journal:  Sci Signal       Date:  2011-05-31       Impact factor: 8.192

3.  Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesis.

Authors:  Jennifer E Saik; Daniel J Gould; Aakash H Keswani; Mary E Dickinson; Jennifer L West
Journal:  Biomacromolecules       Date:  2011-06-15       Impact factor: 6.988

4.  EphrinBs send mixed messages.

Authors:  Michael Soskis; John Salogiannis; Michael Greenberg
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

5.  EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

Authors:  Francesco La Rocca; Irma Airoldi; Emma Di Carlo; Pina Marotta; Geppino Falco; Vittorio Simeon; Ilaria Laurenzana; Stefania Trino; Luciana De Luca; Katia Todoerti; Oreste Villani; Martin Lackmann; Fiorella D'Auria; Francesco Frassoni; Antonino Neri; Luigi Del Vecchio; Pellegrino Musto; Daniela Cilloni; Antonella Caivano
Journal:  Cell Oncol (Dordr)       Date:  2017-07-18       Impact factor: 6.730

6.  To phosphorylate or not to phosphorylate: Selective alterations in tyrosine kinase-inhibited EphB mutant mice.

Authors:  Dhanasak Dhanasobhon; Elise Savier; Vincent Lelievre
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

7.  Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.

Authors:  Michael H Davies; David O Zamora; Justine R Smith; Michael R Powers
Journal:  Microvasc Res       Date:  2009-02-13       Impact factor: 3.514

8.  Truncated EphA2 likely potentiates cell adhesion via integrins as well as infiltration and/or lodgment of a monocyte/macrophage cell line in the red pulp and marginal zone of the mouse spleen, where ephrin-A1 is prominently expressed in the vasculature.

Authors:  Naoko Konda; Noritaka Saeki; Shingo Nishino; Kazushige Ogawa
Journal:  Histochem Cell Biol       Date:  2016-09-24       Impact factor: 4.304

9.  Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.

Authors:  Danmei Zhou; Kehan Ren; Jigang Wang; Hong Ren; Wenlin Yang; Wenjuan Wang; Qiong Li; Xiuping Liu; Feng Tang
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967

10.  Ligand-dependent activation of EphA4 signaling regulates the proteolysis of amyloid precursor protein through a Lyn-mediated pathway.

Authors:  Wei-Bin Lai; Bo-Jeng Wang; Ming-Kuan Hu; Wen-Ming Hsu; Guor Mour Her; Yung-Feng Liao
Journal:  Mol Neurobiol       Date:  2013-11-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.